DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this Phase III trial is to confirm the efficacy of intravaginal
dehydroepiandrosterone (DHEA) in postmenopausal women with vaginal atrophy.